LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Search

Alcon Inc

Closed

SectorHealthcare

73.34 -1.49

Overview

Share price change

24h

Current

Min

73.05

Max

74.58

Key metrics

By Trading Economics

Income

-21M

217M

Sales

104M

2.7B

P/E

Sector Avg

37.444

57.05

Dividend yield

0.45

Profit margin

7.984

Employees

25,942

EBITDA

-144M

521M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+30.01% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.45%

2.52%

Next Earnings

4 maj 2026

Market Stats

By TradingEconomics

Market Cap

-3.8B

37B

Previous open

74.83

Previous close

73.34

News Sentiment

By Acuity

50%

50%

158 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Alcon Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 mar 2026, 14:42 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Lensar Share Slide on Terminated Merger Deal With Alcon

16 mar 2026, 21:37 UTC

Acquisitions, Mergers, Takeovers

Lensar and Alcon Agree to Terminate Merger

6 sty 2026, 15:11 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 gru 2025, 18:51 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 gru 2025, 15:54 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 gru 2025, 14:32 UTC

Acquisitions, Mergers, Takeovers

Alcon Upgrades Offer Price for Staar Surgical

16 mar 2026, 20:59 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mar 2026, 20:59 UTC

Acquisitions, Mergers, Takeovers

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mar 2026, 20:59 UTC

Acquisitions, Mergers, Takeovers

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mar 2026, 20:57 UTC

Acquisitions, Mergers, Takeovers

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 lut 2026, 22:29 UTC

Acquisitions, Mergers, Takeovers

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 lut 2026, 22:29 UTC

Acquisitions, Mergers, Takeovers

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 lut 2026, 22:28 UTC

Acquisitions, Mergers, Takeovers

LENSAR Provides Update on Pending Acquisition by Alcon

24 lut 2026, 21:41 UTC

Earnings

Alcon 4Q Rev $2.72B >ALC.EB

7 sty 2026, 01:00 UTC

Acquisitions, Mergers, Takeovers

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 sty 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 sty 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 sty 2026, 15:21 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 sty 2026, 14:56 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 sty 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 sty 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 sty 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 sty 2026, 14:13 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 gru 2025, 14:17 UTC

Acquisitions, Mergers, Takeovers

Alcon Ups Offer Price for Staar Surgical

9 gru 2025, 13:34 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 gru 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 gru 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 gru 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 gru 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 gru 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

Peer Comparison

Price change

Alcon Inc Forecast

Price Target

By TipRanks

30.01% upside

12 Months Forecast

Average 95.35 USD  30.01%

High 118.97 USD

Low 75.139 USD

Based on 14 Wall Street analysts offering 12 month price targets forAlcon Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

9

Buy

4

Hold

1

Sell

Technical Score

By Trading Central

95.77 / 97.61Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

158 / 349 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat